These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38597064)

  • 21. A critical appraisal of the pharmacological management of stable angina.
    Farmakis D; Xanthopoulos A; Triposkiadis F
    Hellenic J Cardiol; 2021; 62(2):135-138. PubMed ID: 33540054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimetazidine for stable angina pectoris.
    Cross HR
    Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational medical therapy for stable angina pectoris.
    Hoekenga D; Abrams J
    Am J Med; 1984 Feb; 76(2):309-14. PubMed ID: 6141729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy.
    Jiang J; Cong H; Zhang Y; Li Z; Tao G; Li X; Qing L; Tan N; Zhao Z; Dong Y; Ji Z; Chen Y; Ge J; He B; Sun Y; Cao K; Huo Y
    Int J Med Sci; 2017; 14(5):477-483. PubMed ID: 28539824
    [No Abstract]   [Full Text] [Related]  

  • 30. Beneficial effects of betaxolol, a selective antagonist of beta-1 adrenoceptors, on exercise-induced myocardial ischemia in patients with coronary vasospasm.
    Suzuki J; Watanabe K; Tsuruoka T; Sueda S; Funada J; Kitakaze M; Sekiya M
    Int J Cardiol; 2003 Oct; 91(2-3):227-32. PubMed ID: 14559135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of drug therapy in stable angina pectoris.
    Savonitto S; Ardissino D
    Cardiovasc Drugs Ther; 1998 May; 12(2):197-210. PubMed ID: 9652879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-Blockers and Calcium Channel Blockers: First Line Agents.
    Pascual I; Moris C; Avanzas P
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):357-365. PubMed ID: 27576497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of calcium antagonists in ischaemic heart disease.
    Pepine CJ
    Eur Heart J; 1995 Aug; 16 Suppl H():19-24. PubMed ID: 8846801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
    Steg PG; Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox KM;
    PLoS One; 2012; 7(5):e36284. PubMed ID: 22570699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of ranolazine in patients with stable angina pectoris.
    Khera S; Kolte D; Aronow WS
    Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
    Cleophas TJ; van der Sluijs J; van der Vring JA; Daniëls MC; Holwerda KJ; Withagen AJ; Schelling A; Hendriks MG; Zwinderman AH
    J Clin Pharmacol; 1999 Jul; 39(7):738-46. PubMed ID: 10392329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unstable angina. Rational approach to management.
    Flaherty JT
    Am J Med; 1984 Jun; 76(6A):52-7. PubMed ID: 6146257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patients with chronic stable angina at low risk for serious cardiac events.
    Thadani U
    Am J Cardiol; 1997 Jun; 79(12B):24-30. PubMed ID: 9223354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta blockers in the treatment of angina pectoris].
    Hadzi Pesić Lj
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():35-8. PubMed ID: 18193808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.